Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Cancer Research|January 1, 1985
Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophagesJ C Hengst, J Kan-Mitchell, R A Kempf, et al.Cancer|July 1, 1978
Combination chemotherapy for advanced breast cancer: two regimens containing adriamycinG T Kennealey, B Boston, M S Mitchell, et al.Bulletin of the New York Academy of Medicine|January 1, 1989
Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanomaM S Mitchell, R A Kempf, W Harel, et al.The Laryngoscope|June 17, 1998
Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head and neck by intra-arterial chemoradiationR A Weisman, R D Christen, V E Jones, et al.American Journal of Clinical Oncology|April 1, 1996
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921)L E Flaherty, P Y Liu, M S Mitchell, et al.Hybridoma|April 1, 1989
Monoclonal antibody L/1C2 reactive with a human carcinoma associated antigenD A Johnson, M C Gutowski, E K Berger, et al.Cancer Research|January 1, 1985
Cytotoxic activity of human pulmonary alveolar macrophagesJ Kan-Mitchell, J C Hengst, R A Kempf, et al.Cancer Immunology, Immunotherapy : CII|July 1, 1993
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapyJ Kan-Mitchell, X Q Huang, L Steinman, et al.Diabetes|April 30, 2003
Genetic variation in the small heterodimer partner gene and young-onset type 2 diabetes, obesity, and birth weight in U.K. subjectsSimon M S Mitchell, Michael N Weedon, Katharine R Owen, et al.Journal of Biological Response Modifiers|February 1, 1986
Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinomaR A Kempf, S M Grunberg, J R Daniels, et al.Pageof 14